Uric acid elevation in pediatric patients with dilated cardiomyopathy and prediction of mortality

Yong Han1, Cheng Chen1, Suyuan Qin1

  • 1Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Insights

Elevated serum uric acid (SUA) levels predict mortality in children with dilated cardiomyopathy (DCM). Higher SUA levels significantly increase the risk of death, especially in younger children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Biomarker Discovery

Background:

  • Pediatric dilated cardiomyopathy (DCM) is a leading cause of heart failure in children.
  • Effective prognostic markers are urgently needed for risk stratification and management.

Purpose of the Study:

  • To investigate the association between serum uric acid (SUA) levels and mortality in children with DCM.
  • To determine if SUA can serve as a prognostic biomarker in this population.

Main Methods:

  • A retrospective study of 145 children diagnosed with DCM.
  • Analysis of serum uric acid (SUA) levels and all-cause mortality.
  • Kaplan-Meier curves, multivariate Cox models, and restricted cubic spline (RCS) models were used.

Main Results:

  • Elevated SUA levels were significantly associated with increased 1-year and overall mortality in pediatric DCM.
  • The highest SUA tertile showed a substantially greater risk of mortality.
  • Age modified the association, with a linear relationship in children ≤10 years and a U-shaped relationship in those >10 years.

Conclusions:

  • Serum uric acid (SUA) is a significant predictor of mortality in pediatric DCM.
  • SUA levels may be valuable biomarkers for risk stratification in pediatric DCM patients.
  • Age is a critical factor influencing the prognostic value of SUA.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
68
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
162
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77